Internal Medicine, Gastroenterology · Voorhees, NJ
NPI
1760447841
Since 2006
Specialty
Internal Medicine, Gastroenterology
Code 207RG0100X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
1000 South Burnt Mill Road
Voorhees, NJ, 08043
Phone (856) 795-5950
Groups this clinician bills Medicare through
Medicare paid, 2024
$174K
12,499 services
Medicare patients, 2024
275
Average age 75
Drug cost, 2024
$205K
617 prescriptions
Company payments, 2025
$1,450
From 17 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Tusharsindhu C Chauhan was code J3380 (injection, vedolizumab, intravenous, 1 mg), 4,800 times for 14 patients. In total Tusharsindhu C Chauhan billed 12,499 services in 48 codes, and Medicare paid $174K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-10-09.
| Code |
|---|
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J3380 Injection, vedolizumab, intravenous, 1 mg | Office | 4,800 | 14 | $17.47 | $84K |
| 99214 Office E&M - Established | Office | 79 | 70 | $110.58 | $8,736 |
| 43239 Upper GI Endoscopy | Facility | 63 | 60 | $68.29 | $4,302 |
| 99232 Hospital E&M - Subsequent | Facility | 58 | 41 | $69.86 | $4,052 |
| 99213 Office E&M - Established | Office | 44 | 37 | $80.88 | $3,559 |
| 99233 Hospital E&M - Subsequent | Facility | 41 | 31 | $105.26 | $4,316 |
| 45380 Lower GI Endoscopy - Other | Facility | 36 | 35 | $84.88 | $3,056 |
| 99204 Office E&M - New | Office | 34 | 34 | $136.99 | $4,658 |
| 99215 Office E&M - Established | Office | 33 | 30 | $156.95 | $5,179 |
| 99231 Hospital E&M - Subsequent | Facility | 30 | 24 | $43.89 | $1,317 |
| 99222 Hospital E&M - Initial | Facility | 30 | 30 | $115.99 | $3,480 |
| 45385 Colonoscopy - Lesion Removal | Facility | 27 | 25 | $203.27 | $5,488 |
| 96413 Chemotherapy Administration | Office | 18 | 15 | $120.33 | $2,166 |
| 99223 Hospital E&M - Initial | Facility | 14 | 14 | $153.66 | $2,151 |
| 99203 Office E&M - New | Office | 14 | 14 | $94.36 | $1,321 |
By year: 2022 $230K for 13,817 services; 2023 $275K for 22,007 services; 2024 $174K for 12,499 services.
Medicare prescription drug claims, 2024
In 2024, the drug Tusharsindhu C Chauhan prescribed most often to Medicare patients was Pantoprazole Sodium, with 197 prescriptions and refills. In total Tusharsindhu C Chauhan wrote 617 Medicare prescriptions that cost $205K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Pantoprazole Sodium Generic | 197 | 493 | 73 | $2,592 |
| Omeprazole Generic | 79 | 210 | 29 | $1,303 |
| Famotidine Generic | 57 | 161 | 22 | $624 |
| Linzess Linaclotide | 42 | 54 | 11 | $29K |
| Clenpiq Sod Picosulf/Mag Ox/Citric Ac | 40 | 40 | 37 | $6,768 |
| Sod Sulf-Potass Sulf-Mag Sulf Sodium, Potassium,mag Sulfates | 23 | 23 | 22 | $1,471 |
| Mesalamine Generic | 18 | 36 | Under 11 | $16K |
| Gavilyte-C Peg3350/Sod Sulf,bicarb,cl/Kcl | 14 | 14 | 13 | $220 |
| Creon Lipase/Protease/Amylase | 14 | 17 | Under 11 | $12K |
| Esomeprazole Magnesium Generic | 12 | 36 | Under 11 | $501 |
| Cholestyramine Cholestyramine (With Sugar) | 12 | 14 | Under 11 | $722 |
| Potassium Phosphate Potassium Phos,m-Basic-D-Basic | 11 | 11 | Under 11 | $1,141 |
Brand drugs: 154 claims; generic drugs: 463 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Tusharsindhu C Chauhan $1,450 ($1,450 in general payments such as food, travel and fees) from 17 companies. The largest payer was Abbvie Inc. with $379.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 23 | $379 |
| Madrigal Pharmaceuticals MDGL | 8 | $241 |
| Regeneron Healthcare Solutions, Inc. REGN | 6 | $117 |
| Janssen Biotech, Inc. JNJ | 5 | $104 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 5 | $87.28 |
| Celltrion USA Inc. 068270.KS | 5 | $86.96 |
| QOL Medical, LLC | 4 | $77.81 |
| Lilly USA, LLC LLY | 3 | $54.09 |
| Ardelyx, Inc. ARDX | 3 | $53.97 |
| Phathom Pharmaceuticals, Inc. PHAT | 3 | $51.76 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.